Alpha Cognition Inc. grants stock options to new employee. The NASDAQ-listed biopharmaceutical company's Compensation Committee approved inducement awards of 20,000 nonstatutory stock options at an exercise price of $6.49 per share on April 14, 2026. The options vest over three years with 25% vesting after one year and remaining shares vesting monthly over the following 24 months, contingent on continued employment. This grant aligns with Nasdaq Listing Rule 5635(c)(4) for inducement awards to newly hired employees. Alpha Cognition develops novel therapeutics for neurodegenerative disorders including Alzheimer's disease and cognitive impairment related to mild traumatic brain injury, positioning itself in a competitive biotech market addressing significant unmet medical needs.
Post from MarketNews_en
Log in to interact with content.